Proud to be part of this and highlights the #progress but also the #need for translational endpoints in future GYN clinical trials! #dobetterforourpatients#thankstoNCI for sponsoring this planning meeting!
State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report in @JCOPO_ASCO https://t.co/MQ2Fh4h732
From moonshot 🚀 to groundshot 🌏, how one QHS oncologist is advocating for improved widespread access to basic cancer treatment to those who need it most.
➡️https://t.co/jI0aeBYpje
I forced a bot to read 1000 #internalmedicine personal statements & write its own. The syntax is a little off, but this bot has the template down! (Credit to @KeatonPatti's shtick.)
#meded#match2019
Disclosures: I read every PS in detail, and I love interviewing applicants.
New paper in the @JournalCancer from Chris Booth group led by @dmeyzie looking at trends in drug revenue among major pharmaceutical companies. Oncology is the goose that lays golden eggs, that explains why oncology trials can be so flawed! https://t.co/6ioFS4RKDE @queenscce
@jm_mcgrath@YoniFreedhoff I could see and hear them from my cancer clinic window all morning. Incredibly distracting…and beyond selfish, they are screaming at the immunocompromised pts most at risk from the unvaccinated.